News and Press Releases
Press releases
Dr. Ashish M. Kamat Joins Theralase Medical and Scientific Advisory Board
Toronto, Ontario – December 2, 2014 Theralase Technologies Inc. (“Theralase”) (TLT:TSXV) (TLTFF: OTC Link®) announced today that Ashish M. K...
0Theralase Releases 3Q2014 Financials
Toronto, Ontario – November 28, 2014 Theralase Technologies Inc. (“Theralase”) (TLT: TSXV) (TLTFF: OTC Link®) released its third quarter 201...
0Theralase Releases Annual General Meeting Video
Toronto, Ontario – November 25, 2014 Theralase Technologies Inc. (“Theralase”) (TSXV: TLT) (TLTFF: OTCBB) announced today that it has release...
0Theralase Further Validates Anti-Cancer Memory Response
Toronto, Ontario – November 12, 2014 Theralase Technologies Inc. (“Theralase”) (TSXV: TLT) (TLTFF: OTCBB) announced today that in new preclin...
0Theralase Presents Latest Research on Destruction of Cancer and Bacteria at International Conference
Toronto, Ontario – October 16, 2014 –Theralase Technologies Inc. (“Theralase®”) (TSXV: TLT) (TLTFF: OTC Link®) announced today that it ha...
0Theralase Partners with SAFC in Manufacture of Anti-Cancer Drugs
Toronto, Ontario – October 7, 2014 –Theralase Technologies Inc. (“Theralase®”) (TSXV: TLT) (TLTFF: OTC Link®) announced today that it has...
0Theralase Files Voluntary Annual Information Form
Toronto, Ontario – September 24, 2014 –Theralase Technologies Inc. (“Theralase®”) (TSXV: TLT) (TLTFF: OTC Link®) announced today that it ...
0Theralase Partners with Montreal’s JSS Medical Research to Bring Innovative Bladder Cancer Treatment to Market
Toronto, Ontario / ACCESSWIRE / September 11, 2014 / To take advantage of the vastly improved business climate in Quebec, Theralase Technologies In...
0Theralase Launches Multi Wavelength Laser for Cancer Destruction
Toronto, Ontario / ACCESSWIRE / September 9, 2014 / Theralase Technologies Inc. (“Theralase”) (TLT.V) (TLTFF: OTC Link(R)) announced today that it ...
0Theralase Releases 2Q2014 Financials
Toronto, Ontario / ACCESSWIRE / August 29, 2014 / Theralase Technologies Inc. (“Theralase”) (TLT:TSXV) (TLTFF:OTC Link) released its second quarter...
0in the news
July 6, 2023
Vrian Crombie Radio Interview with Roger DuMoulin-White - President and Chief Executive Officer
may 18, 2023
Promising Developments in the Theralase® Project of Intravesical Photodynamic Therapy for BCG Unresponsive Bladder Cancer - Girish Kulkarni
Let's Stay in Touch
Sign up to our newsletter to stay informed on news and updates from Theralase Technologies Inc.
